Ingersoll-Rand Inc’s recent filing unveils that its insider Schiesl Andrew R unloaded Company’s shares for reported $1.15 million on Feb 18 ’25. In the deal valued at $87.05 per share,13,228 shares were sold. As a result of this transaction, Schiesl Andrew R now holds 30,846 shares worth roughly $2.58 million.
Then, Schiesl Andrew R bought 13,228 shares, generating $1,151,495 in total proceeds.
Before that, Scheske Michael J sold 2,531 shares. Ingersoll-Rand Inc shares valued at $246,621 were divested by the VP, Chief Accounting Officer at a price of $97.44 per share. As a result of the transaction, Scheske Michael J now holds 11,910 shares, worth roughly $0.99 million.
Stifel downgraded its Ingersoll-Rand Inc [IR] rating to a Hold from a a Buy in a research note published on November 18, 2024; the price target was decreased to $107 from $112. Morgan Stanley began covering IR with “an Equal-weight” recommendation on September 06, 2024.
Price Performance Review of IR
On Monday, Ingersoll-Rand Inc [NYSE:IR] saw its stock fall -2.01% to $83.52. Over the last five days, the stock has gained 1.11%. Ingersoll-Rand Inc shares have fallen nearly -7.67% since the year began. Nevertheless, the stocks have fallen -7.45% over the past one year. While a 52-week high of $106.03 was reached on 01/31/25, a 52-week low of $79.96 was recorded on 03/04/25. SMA at 50 days reached $89.25, while 200 days put it at $94.07.
Levels Of Support And Resistance For IR Stock
The 24-hour chart illustrates a support level at 82.21, which if violated will result in even more drops to 80.89. On the upside, there is a resistance level at 84.99. A further resistance level may holdings at 86.46. The Relative Strength Index (RSI) on the 14-day chart is 40.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.80%. Stochastics %K at 57.93% indicates the stock is a holding.
The most recent change occurred on March 12, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”a Neutral”‘ rating along with a $92 price target.
